2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Chronic Pain Market?

The chronic pain market is anticipated to expand due to the high number of people living with persistent or extended pain. These individuals, often experiencing pain that goes beyond the typical healing phase or persists for more than three months, represent a significant market for pain management solutions. This need for effective means of dealing with pain includes pharmaceuticals and medical devices and also fosters innovation and development within the industry. For example, the Australian Institute of Health and Welfare revealed in June 2024 that around 4.0 million Australians, equivalent to 16% of the population, had back problems in 2022. By 2023, these issues became the third main cause of disease load, accounting for 4.3% of Australia’s overall disease burden. Similarly, a report released in February 2024 by the Institute for Health Metrics and Evaluation, a leading public health and research agency in the US, projected that the global incidence of neck pain would reach 269 million by 2050. This range, from 219 to 322 million, indicates a rise of 32.5% (between 23.9% and 42.3%) compared to 2020. As such, the chronic pain patient population’s prevalence underpins the chronic pain market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

#How Will the CAGR of the Chronic Pain Market Influence Its Overall Growth by 2034?

Over recent years, there’s been robust growth in the chronic pain market size. Future projections show a surging trend from $78.79 billion in 2024 to an impressive $84.96 billion in 2025 with a compound annual growth rate (CAGR) of 7.8%. Factors that have influenced growth in the previous period include injury and trauma, surgical procedures, inflammatory conditions, nerve damage and neuropathy, and the deficiency of efficient treatments.

The market for chronic pain is anticipated to experience significant expansion in the coming years. It is projected to reach a valuation of $117.74 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.5%. Factors such as the aging population, the growth of telemedicine, increased awareness of public health, advancements in genetic research and precision medicine, and psychosocial stressors can be credited for this predicted growth. The forecast period also shows major tendencies towards the use of wearable devices, provision of pain education and support groups, a comprehensive approach to pain management, non-opioid methods of pain management, and the application of regenerative medicine for pain relief.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11970

What New Market Trends Are Reshaping theChronic Pain Market and Its Opportunities?

A significant trend emerging in the chronic pain market is the rise of alternative pain management technologies. Corporations in the chronic pain sector are honing their attention on creating novel, portable, and user-friendly nerve stimulation apparatus that utilize electrical shocks to spark nerves and mitigate pain, providing a non-invasive method of pain management to maintain their market standing. For example, in December 2022, Abbott Laboratories, a US-based medical firm specializing in diagnostics, medical gadgets, nutrition and branded generic drugs, introduced Eterna, an advanced spinal cord stimulation (SCS) system that is presently the tiniest implantable and rechargeable device in the chronic pain treatment market. Eterna SCS uses Abbott’s unique low-dose BurstDR stimulation, the only waveform technology with substantial clinical proof (1A evidence), showing a 23% higher reduction in pain compared to standard waveform technology methods.

Who Are the Leading Market Players Fueling Growth in the Chronic Pain Market Trend?

Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

How is the Global Chronic Pain Market Segemented?

The chronic pain market covered in this report is segmented –

1) By Product: Drug, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By End User: Hospitals, Clinics, Research Organization

Subsegments:

1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids

2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

Which Geographics are Influencing the Growth of the Chronic Pain Market?

North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Chronic Pain Maret 2025, By The Business Research Company:

Aerospace Bearings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/aerospace-bearings-global-market-report

Aerospace And Defense Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/aerospace-defense-global-market-report

Vanadium Ore Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vanadium-ore-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: